Buruli ulcer recurrence, Benin

Emerging Infectious Diseases

Volumn 11, Issue 4, 2005, Pages 584-589

  Debacker, Martine ^a   Aguiar, Julia ^b   Steunou, Christian ^b   Zinsou, Claude ^a,b   Meyers, Wayne M ^c   Portaels, Françoise ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Ctr Sanitaire et Nutr Gbemoten   (Benin)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BENIN; BURULI ULCER; CHILD; CONFIDENCE INTERVAL; DISEASE COURSE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; RECURRENCE RISK; RECURRENT DISEASE; WORLD HEALTH ORGANIZATION;

EID: 16244419037     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1104.041000     Document Type: Article

References (29)

1. World Health Organization. Epidemiology. In: Buruli ulcer-Mycobacterium ulcerans infection. Asiedu K, Scherpbier R, Raviglione M, editors. Geneva: The Organization; 2000. p. 9-14.
2. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Guedenon A, et al. Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital, southern Benin, 1997-2001. Emerg Infect Dis. 2004;10: 1391-8.
3. World Health Organization. Surgical treatment. In: Buruli ulcer. Management of Mycobacterium ulcerans disease. Buntine J, Crofts K, editors. Geneva: The Organization; 2001. p. 28-40.
4. Grosset J. Essai clinique d'un traitement de l'ulcère de Buruli par l'association rifampicine-streptomycine. Le Bulletin de l'ALLF (Association des Léprologues de Langue Française). 2004;14:33.
5. Amofah G, Asamoah S, Afram-Gyening C. Effectiveness of excision of pre-ulcerative Buruli lesions in field situations in a rural district in Ghana. Trop Doct. 1998;28:81-3.
6. Teelken MA, Stienstra Y, Ellen DE, Quarshie E, Klutse E, van der Graaf WT, et al. Buruli ulcer: differences in treatment outcome between two centres in Ghana. Acta Tropica. 2003;88:51-6.
7. Aguiar J, Steunou C. Les ulcères de Buruli en zone rurale au Bénin: prise en charge de 635 cas. Med Trop (Mars). 1997;57:83-96.
8. Aujoulat I, Johnson C, Zinsou C, Guédénon A, Portaels F. Psychosocial aspects of health seeking behaviours of patients with Buruli ulcer: results of a qualitative study among 130 adults and 30 children in southern Benin. Trop Med Int Health. 2003;8:750-9.
9. World Health Organization. Buruli ulcer. Diagnosis of Mycobacterium ulcerans disease. A manual for health care providers. Portaels F, Johnson P, Meyers WM, editors. Geneva: The Organization; 2001. p. 92.
10. Meyers WM, Shelly WM, Connor DH, Meyers EK. Human Mycobacterium ulcerans infections developing at sites of trauma to skin. Am J Trop Med Hyg. 1974;23:919-23.
11. Portaels F, Zinsou C, Aguiar J, Debacker M, de Biurrun E, Guédénon A, et al. Les atteintes osseuses dans l'ulcère de Buruli: à propos de 73 cas. Bulletin des Séances de l'Académie Royale des Sciences d'Outre-Mer. 2003;49:161-90.
12. Lunn HF, Connor DH, Wilks NE, Bamley GR, Kamunvi F, Clancey JK, et al. Buruli (mycobacterial) ulceration in Uganda (a new focus of Buruli ulcer in Madi District, Uganda). East Afr Med J. 1965;42:275-88.
13. World Health Organization. Buruli ulcer. Management of Mycobacterium ulcerans disease. Butine J, Crofts K, editors. Geneva: The Organization; 2001.
14. Godfrey-Faussett P, Githui W, Batchelor B, Brindle R, Paul J, Hawken M, et al. Recurrence of HIV-related tuberculosis in an endemic area may be due to relapse or reinfection. Tuber Lung Dis. 1994;75:199-202.
15. Muelder K, Nourou A. Buruli ulcer in Benin. Lancet. 1990;336:1109-11.
16. Jantunen ME, Saxén H, Salo E, Siitonen A. Recurrent urinary tract infections in infancy: relapses or reinfections? J Infect Dis. 2002;185:375-9.
17. Krüüner A, Pehme L, Ghebremichael S, Koivula T, Hoffner S, Mikelsaar M. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2002;35:146-55.
18. Stragier P, Ablordey A, Meyers WM, Portaels F. Genotyping Mycobacterium ulcerans and Mycobacterium marinum by using interspersed repetitive units. J Bacteriol. 2005;187:1639-47.
19. Gooding T, Johnson P, Smith M, Kemp A, Robins-Browne R. Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect Immun. 2002;70:5562-7.
20. Stienstra Y, van der GraafW, te Meerman G, The T, de Leij L, van der Werf T. Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors. Trop Med Int Health. 2001;6:554-62.
21. Meyers WM, Portaels F. Buruli ulcer disease (Mycobacterium ulcerans disease). In: Report of the 5th WHO Advisory Group meeting on Buruli ulcer, 11-14 March 2002. Geneva: World Health Organization; 2003.
22. Meyers WM, Shelly WM, Connor DH. Heat treatment of Mycobacterium ulcerans infections without surgical excision. Am J Trop Med Hyg. 1974;23:924-9.
23. Portaels F, Traore H, De Ridder K, Meyers WM. In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Antimicrob Agents Chemother. 1998;42:2070-3.
24. Thangaraj HS, Adjei O, Allen BW, Portaels F, Evans MR, Banerjee DK, et at. In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin, and rifampin against Ghanaïan isolates of Mycobacterium ulcerans. J Antimicrob Chemother. 2000;45:231-3.
25. Marsollier L, Honore N, Legras P, Manceau AL, Kouakou H, Carbonnelle B, et al. Isolation of three Mycobocterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice. Antimicrob Agents Chemother. 2003;47:1228-32.
26. Dega H, Bentoucha A, Robert J, Jarlier V, Grosset J. Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice. Antimicrob Agents Chemother. 2002;46:3193-6.
27. Revill WD, Morrow RH, Pike MC, Ateng J. A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Lancet. 1973;2:873-7.
28. Fehr H, Egger M, Senn I. Cotrimoxazole in the treatment of Mycobacterium ulcerans infection (Buruli ulcer) in West Africa. Trop Doct. 1994;24:61-3.
29. Johnson RC, Makoutodé M, Sopoh GE, Elsen P, Gbovi J, Pouteau LH, et al. Buruli ulcer in Benin. Emerg Infect Dis. 2005;11:500-1.